comprehensive -WSS

comprehensive

author：comprehensive 2025-09-27 15:00:02 - browse：887

New Sanofi Genzyme president Bill Sibold is the first person without any ties to Henri Termeer (inset) to lead the company. Jonathan Wiggs/Globe staff

CAMBRIDGE, Mass. — When drug giant Sanofi restructured its global business two years ago, its Genzyme division got a new name, Sanofi Genzyme, explicitly tying it to the French parent company. It also got new responsibilities and a larger “specialty care” portfolio covering everything from enzyme replacement to cancer and multiple sclerosis drugs.

Last week, Sanofi Genzyme — still the largest Massachusetts biotech, with about 5,000 workers — also got a new president, Bill Sibold. He’s the first one without any ties to the old Genzyme, an independent company that pioneered the rare-disease business model and catalyzed the local life sciences boom before accepting Sanofi’s $20.1 billion takeover offer in 2011.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

WSS

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Biotech investment managers search for lucrative opportunities

Abridge raises $150m as clinical notes automation market heats up

Mirador, a new biotech startup, launches with $400 million

'Patient friction coefficient' can gauge a clinical trial's patient burden

Surgeons perform first xenotransplant using CRISPR'd pig kidney

entertainment

comprehensive

Wikipedia

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Yancopoulos of Regeneron works to expand Dupixent success

Continuity nursing helped my family in our darkest PICU moments

Elevance, SCAN deals highlight health insurer acquisition scrutiny

In Memoriam: Notable people who died in 2023

FDA warns medical device makers about rise in fabricated data

Hepatitis C has a cure — but many Americans still lack access to it

CRISPR technology availability, affordability needs to be expanded

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

focus

Chinese researcher claims birth of first gene

Secretariat’s lessons for human medicine

Opioid cravings were reduced by anti

Flagship Pioneering startup Sonata Therapeutics lays off 21

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Chinese researcher claims birth of first gene

hotspot

leisure time

explore

Wikipedia